Literature DB >> 1329734

Molecular cloning, functional expression and pharmacological characterization of a human bradykinin B2 receptor gene.

D Eggerickx1, E Raspe, D Bertrand, G Vassart, M Parmentier.   

Abstract

The gene encoding a putative G protein-coupled receptor (HG10) was cloned from human genomic DNA by low stringency PCR and found to be homologous to the recently described rat bradykinin B2 receptor. The receptor was expressed in xenopus oocytes and stably transfected CHO cell lines. Binding studies demonstrated that HG10 encodes a high affinity BK receptor with an apparent Kd of 150 pM. Displacement by BK agonists and antagonists allowed the characterization of the receptor as a B2 subtype. Functional coupling to the Ca(2+)-phosphatidylinositol cascade was demonstrated in transfected CHO cells where inositol phosphates accumulation and intracellular calcium concentration were elevated in response to BK stimulation. The agonistic and antagonistic properties of BK analogs do not match strictly the pharmacological profile described for the rat or guinea pig B2 receptor subtypes or the putative B3 subtype. This discrepancy is attributed either to species variability or to differences in the coupling efficiency of receptors to the transduction cascade in different cell types. From our results, the existence of B3 receptors and of B2 subtypes appears questionable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329734     DOI: 10.1016/0006-291x(92)90445-q

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Molecular and pharmacological evidence for modulation of kinin B(1) receptor expression by endogenous glucocorticoids hormones in rats.

Authors:  D A Cabrini; M M Campos; K S Tratsk; V F Merino; J A Silva ; G E Souza; M C Avellar; J B Pesquero; J B Calixto
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Selective labelling of bradykinin receptor subtypes in WI38 human lung fibroblasts.

Authors:  S B Phagoo; M Yaqoob; M C Brown; G M Burgess
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.

Authors:  J L Paquet; J M Luccarini; C Fouchet; E Defrêne; B Loillier; C Robert; P Bélichard; B Cremers; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

5.  A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.

Authors:  Francesca Bellucci; Stefania Meini; Paola Cucchi; Claudio Catalani; Wolfgang Reichert; Sabrina Zappitelli; Luigi Rotondaro; Laura Quartara; Alessandro Giolitti; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

6.  Bradykinin binding sites in healthy and carcinomatous human lung.

Authors:  A Trifilieff; E Lach; P Dumont; J P Gies
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding.

Authors:  J Nardone; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Identification of a B2 bradykinin receptor expressed by PC12 pheochromocytoma cells.

Authors:  J Nardone; C Gerald; L Rimawi; L Song; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.

Authors:  C R Corrêa; D J Kyle; S Chakraverty; J B Calixto
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Pharmacological characterization of bradykinin receptors in canine cultured tracheal smooth muscle cells.

Authors:  C M Yang; S F Luo; H C Hsia
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.